Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

EGRX

Eagle Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · EGRX

All alert types
0.25 USD 0.00 0.00%
As of Feb 5, 2026
1.50 Day range 1.50
0.001 52-week range 3.94
YTD
-64.29%
1 year
-89.36%
Open
1.50
Prev close
0.25
Mkt cap
3.29M
Vol
100
Avg vol
1.63K
EPS
1.73
P/E
0.14
Div yield
0.00%
More statistics
Low
1.50
High
1.50
Forward P/E
0.28
Beta
0.62
Short ratio
3.91
Inst. own
80.90%
Dividend
0.00
Ex-div date
Earnings
Oct 1, 2024
50-d avg
1.49
200-d avg
4.03
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for EGRX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.70 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 10.6×
FY 2012: -22.5×FY 2013: -7.0×FY 2015: 522×FY 2016: 15.1×FY 2017: 15.5×FY 2018: 18.7×FY 2019: 57.8×FY 2020: 52.3×FY 2021: -77.2×FY 2022: 10.6×
FY 2012 5y median 18.7× FY 2022
P/S 1.2×
FY 2012: 9.9×FY 2013: 6.6×FY 2015: 20.4×FY 2016: 6.5×FY 2017: 3.4×FY 2018: 2.8×FY 2019: 4.2×FY 2020: 3.3×FY 2021: 3.9×FY 2022: 1.2×
FY 2012 5y median 3.3× FY 2022
P/B 1.6×
FY 2012: 66.0×FY 2013: 3.8×FY 2015: 15.0×FY 2016: 8.1×FY 2017: 4.5×FY 2018: 3.7×FY 2019: 4.6×FY 2020: 3.4×FY 2021: 3.8×FY 2022: 1.6×
FY 2012 5y median 3.7× FY 2022
P/FCF 7.5×
FY 2012: -22.9×FY 2013: -9.1×FY 2015: -117×FY 2016: 37.9×FY 2017: 15.0×FY 2018: 11.4×FY 2019: 15.0×FY 2020: 12.9×FY 2021: 23.8×FY 2022: 7.5×
FY 2012 5y median 12.9× FY 2022
EV/EBITDA 5.0×
FY 2012: -14.9×FY 2013: -5.5×FY 2015: 472×FY 2016: 21.4×FY 2017: 9.5×FY 2018: 13.9×FY 2019: 25.7×FY 2020: 18.8×FY 2021: 705×FY 2022: 5.0×
FY 2012 5y median 18.8× FY 2022
EV/Sales 1.2×
FY 2012: 9.1×FY 2013: 5.4×FY 2015: 19.2×FY 2016: 6.2×FY 2017: 3.1×FY 2018: 2.6×FY 2019: 3.9×FY 2020: 3.0×FY 2021: 3.5×FY 2022: 1.2×
FY 2012 5y median 3.0× FY 2022
FCF Yield 13.4%
FY 2012: -4.4%FY 2013: -11.0%FY 2015: -0.9%FY 2016: 2.6%FY 2017: 6.7%FY 2018: 8.8%FY 2019: 6.7%FY 2020: 7.8%FY 2021: 4.2%FY 2022: 13.4%
FY 2012 5y median 7.8% FY 2022

Profitability

Gross Margin 70.0%
FY 2012: 46.0%FY 2013: 38.7%FY 2015: 76.4%FY 2016: 70.8%FY 2017: 75.8%FY 2018: 71.0%FY 2019: 68.9%FY 2020: 75.8%FY 2021: 75.4%FY 2022: 70.0%
FY 2012 5y median 71.0% FY 2022
Operating Margin 25.6%
FY 2012: -61.8%FY 2013: -98.2%FY 2015: 3.9%FY 2016: 28.2%FY 2017: 31.3%FY 2018: 17.2%FY 2019: 11.1%FY 2020: 17.5%FY 2021: 1.6%FY 2022: 25.6%
FY 2012 5y median 17.2% FY 2022
Net Margin 11.3%
FY 2012: -44.2%FY 2013: -94.1%FY 2015: 3.9%FY 2016: 43.0%FY 2017: 21.9%FY 2018: 15.0%FY 2019: 7.3%FY 2020: 6.4%FY 2021: -5.0%FY 2022: 11.3%
FY 2012 5y median 7.3% FY 2022
ROE 15.3%
FY 2012: -294.5%FY 2013: -54.3%FY 2015: 2.8%FY 2016: 53.9%FY 2017: 29.0%FY 2018: 19.8%FY 2019: 8.0%FY 2020: 6.4%FY 2021: -4.9%FY 2022: 15.3%
FY 2012 5y median 8.0% FY 2022
ROIC 15.5%
FY 2012: -195.7%FY 2013: -52.9%FY 2015: 2.8%FY 2016: 30.8%FY 2017: 23.1%FY 2018: 16.7%FY 2019: 6.4%FY 2020: 7.8%FY 2021: 1.3%FY 2022: 15.5%
FY 2012 5y median 7.8% FY 2022
ROA 8.8%
FY 2012: -33.4%FY 2013: -33.7%FY 2015: 2.1%FY 2016: 38.1%FY 2017: 19.2%FY 2018: 13.4%FY 2019: 5.6%FY 2020: 4.7%FY 2021: -3.4%FY 2022: 8.8%
FY 2012 5y median 5.6% FY 2022

Growth (YoY)

Revenue 84.6%
FY 2012: 438.8%FY 2013: 39.6%FY 2015: 0.0%FY 2016: 186.1%FY 2017: 24.9%FY 2018: -9.9%FY 2019: -8.2%FY 2020: -4.1%FY 2021: -8.7%FY 2022: 84.6%
FY 2012 FY 2022
Operating Income 2823.8%
FY 2012: 57.4%FY 2013: -121.8%FY 2015: 0.0%FY 2016: 1984.0%FY 2017: 38.7%FY 2018: -50.5%FY 2019: -40.4%FY 2020: 51.1%FY 2021: -91.6%FY 2022: 2823.8%
FY 2012 FY 2022
EPS (diluted) 513.6%
FY 2012: 68.9%FY 2013: -217.5%FY 2015: 0.0%FY 2016: 3000.0%FY 2017: -34.1%FY 2018: -36.1%FY 2019: -51.7%FY 2020: -13.9%FY 2021: -175.9%FY 2022: 513.6%
FY 2012 FY 2022
Free Cash Flow 81.1%
FY 2012: 62.0%FY 2013: -134.6%FY 2015: 0.0%FY 2016: 380.3%FY 2017: 65.2%FY 2018: -2.8%FY 2019: 5.7%FY 2020: -11.7%FY 2021: -42.8%FY 2022: 81.1%
FY 2012 FY 2022

Financial Health

Current Ratio 1.7×
FY 2012: 1.2×FY 2013: 2.6×FY 2015: 3.6×FY 2016: 2.7×FY 2017: 4.0×FY 2018: 4.1×FY 2019: 4.6×FY 2020: 4.4×FY 2021: 2.3×FY 2022: 1.7×
FY 2012 5y median 4.1× FY 2022
Quick Ratio 1.3×
FY 2012: 1.1×FY 2013: 2.5×FY 2015: 3.1×FY 2016: 2.6×FY 2017: 3.9×FY 2018: 3.9×FY 2019: 4.5×FY 2020: 4.1×FY 2021: 2.0×FY 2022: 1.3×
FY 2012 5y median 3.9× FY 2022
Debt / Equity 0.3×
FY 2012: 0.0×FY 2013: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.3×
FY 2012 5y median 0.2× FY 2022
Net Debt / EBITDA 0.2×
FY 2012: 1.2×FY 2013: 1.2×FY 2015: -29.3×FY 2016: -1.0×FY 2017: -0.9×FY 2018: -0.9×FY 2019: -2.4×FY 2020: -2.2×FY 2021: -80.1×FY 2022: 0.2×
FY 2012 5y median -2.2× FY 2022
Interest Coverage 20.0×
FY 2012: -6.0×FY 2013: -2345×FY 2015: 233×FY 2016: 6669×FY 2017: 65.1×FY 2018: 13.4×FY 2019: 8.1×FY 2020: 12.8×FY 2021: 1.7×FY 2022: 20.0×
FY 2012 5y median 12.8× FY 2022

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2012 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2012 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31